Drug Type Bispecific antibody |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Dren Bio, Inc.Startup |
Active Organization Dren Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | IND Application | US | Dren Bio, Inc.Startup | 31 Jul 2024 |